Cannabis Users Consistently Had Equal or Lower Diabetes Risk Despite Known Metabolic Effects | Research

The takeaway

Despite the known effects of cannabinoids on fat tissue and insulin metabolism, studies consistently found that marijuana users had equal or lower rates of diabetes and obesity compared to non-users.

Read this if you have diabetes or metabolic concerns and want to understand the research on cannabis and metabolic health.

Cannabis users had equal or lower diabetes odds across multiple studies, despite cannabis activating appetite-promoting pathways.

What the researchers found

This review examined the paradoxical relationship between cannabis use and diabetes. The endocannabinoid system is directly involved in fat tissue regulation and glucose/insulin metabolism, and blocking CB1 receptors (with rimonabant) reduced weight and improved metabolic markers. Logically, activating these receptors with cannabis should worsen metabolic health.

Yet the epidemiological evidence consistently showed the opposite. Across multiple studies, marijuana users had either the same or lower odds of diabetes compared to non-users. Similarly, despite the well-known appetite-stimulating effects of cannabis ("the munchies"), marijuana users generally had lower BMI and lower rates of obesity.

The review also covered the endocannabinoid system's role in adipose tissue, insulin sensitivity, metabolic syndrome, and prediabetes, noting that while the biology predicts one outcome, the population-level data show another.

Why it matters

With 29 million Americans having diabetes and cannabis use increasing due to legalization, understanding the metabolic effects of cannabis is a significant public health question. The consistent finding of lower or equal diabetes risk in cannabis users is one of the most counterintuitive results in cannabis epidemiology.

The numbers in context

29 million Americans with diabetes (estimate at time of publication). Studies consistently found either lower or no difference in diabetes odds among cannabis users compared to non-users.

How the study worked

Narrative review examining the human endocannabinoid system, the pharmacology of cannabinoids on adipose tissue and glucose metabolism, and epidemiological studies on the association between marijuana use and obesity, metabolic syndrome, prediabetes, and diabetes.

What this study cannot tell us

Epidemiological studies cannot prove cannabis protects against diabetes. Cannabis users may differ from non-users in many ways (age, activity level, diet) that could explain the association. Observational data is subject to confounding and selection bias. The review was narrative rather than systematic.

How to read the evidence

Moderate evidence from a narrative review synthesizing multiple epidemiological studies with consistent findings, though the paradox remains mechanistically unexplained.

When this study was published

Published in 2016. The cannabis-diabetes relationship continues to be studied with some researchers focusing on specific cannabinoids like THCV.

The bigger picture

The cannabis-metabolism paradox mirrors the broader complexity of the endocannabinoid system. The same system that promotes appetite also appears to have protective metabolic effects at the population level. Understanding this paradox could lead to new approaches for metabolic disease.

Questions still open

What mechanism explains lower diabetes rates in cannabis users? Is it the THC, CBD, other cannabinoids, or something about the lifestyle of cannabis users? Would a randomized trial of cannabis for metabolic syndrome be ethical or feasible? Does the type or potency of cannabis matter?

Common questions

Does cannabis protect against diabetes?

Multiple studies have found that cannabis users have equal or lower rates of diabetes, but this does not prove cannabis protects against diabetes. The association could be explained by differences between users and non-users that researchers have not fully accounted for.

How can cannabis users have lower BMI when cannabis causes "the munchies"?

This is one of the most puzzling findings in cannabis research. Despite acute appetite stimulation, population studies consistently show lower BMI in cannabis users. Proposed explanations include cannabinoid effects on metabolism, changes in gut bacteria, or lifestyle factors associated with cannabis use.

Read the original research

Marijuana Use and Type 2 Diabetes Mellitus: a Review.

Current diabetes reports, 16(11), 117

View on PubMed ↗

Citation

Sidney, Stephen. (2016). Marijuana Use and Type 2 Diabetes Mellitus: a Review.. Current diabetes reports, 16(11), 117.